NONDISCLOSURE AGREEMENT Disclosing Party: Omrix Biopharmaceuticals, Inc. Recipient: Ethicon, Inc.Nondisclosure Agreement • November 26th, 2008 • Omrix Biopharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This NONDISCLOSURE AGREEMENT (this “Agreement”) is made effective as of the 1st day of August, 2008, by and between Omrix Biopharmaceuticals, Inc. (the “Company”) and Ethicon, Inc. (the “Recipient”) to assure the protection and preservation of the confidential and/or proprietary nature of information to be disclosed to the Recipient by the Company.
